Omeprazole

Table   Graphic     exposition period:

Congenital malformations
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
All congenital malformations (majors, minors, majors and minors, or unspecified)1.05 [0.89, 1.24]0%7 studies28,5544,084not evaluable ROB-
Major congenital malformations1.09 [0.91, 1.31]0%5 studies28,4723,082not evaluable ROB-
Hypospadias1.69 [0.86, 3.34]0%4 studies1,5392,211not evaluable ROB-
Congenital hydronephrosis0.90 [0.35, 2.30]0%3 studies32,201not evaluable ROB-
Cleft lip with or without cleft palate0.82 [0.15, 4.34]20%2 studies11,939not evaluable ROB-
Cleft palate1.42 [0.26, 7.72]0%2 studies11,939not evaluable ROB-
Club foot / Talipes equinovarus1.05 [0.36, 3.07]0%2 studies31,939not evaluable ROB-
Congenital heart defects1.39 [0.45, 4.34]53%2 studies5,4361,802not evaluable ROB-
Down syndrom / Trisomy 214.24 [0.35, 50.76]0%2 studies1401not evaluable ROB-
Microcephaly / Small head circumference for gestational age0.98 [0.33, 2.96]0%2 studies138108not evaluable ROB-
Syndactyly1.56 [0.10, 25.51]44%2 studies1,939not evaluable ROB-
Atrial septal defect0.95 [0.44, 2.04]0%2 studies2,062not evaluable ROB-
Cardiac septal defects7.65 [1.27, 46.17]-1 study5139not evaluable ROB14.78 [1.85; .]
Ventricular septal defect1.19 [0.47, 2.98]7%2 studies32,062not evaluable ROB-
8 non statistically significant endpoints reported in only one study

Growth parameters and prematurity
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Preterm (< 37 weeks)1.28 [0.91, 1.78]0%3 studies263451not evaluable ROB-
Low birth weight (< 2500g)1.02 [0.89, 1.18]0%2 studies104,2603,372not evaluable ROB-
1 non statistically significant endpoints reported in only one study

Maternal consequences
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
2 non statistically significant endpoints reported in only one study

Neonatal disorders
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Low Apgar score (< 7) (at 5 min)--0 study-

Intrauterine deaths
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Early intrauterine death (< 22 weeks)1.37 [0.89, 2.11]0%2 studies107409not evaluable ROB-
Late intrauterine deaths (> 22 weeks)1.62 [0.15, 17.97]54%2 studies20435not evaluable ROB-
Ectopic pregnancy--0 study-
Elective/induced termination of pregnancy3.00 [1.72, 5.23]-1 study53296not evaluable ROB5.45 [2.83; .]
2 non statistically significant endpoints reported in only one study